Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis.

Kwangrok Jung Jaewoo Park Jae Hyup Jung Jong-Chan Lee Yong-Tae Kim Jin-Hyeok Hwang

Published in: Gut and liver (2022)

Gemcitabine, cisplatin, and nab-paclitaxel did not improve the PFS or OS compared to that achieved by standard chemotherapy in patients with advanced BTC. The benefits of triplet chemotherapy in advanced BTC require examination in large randomized controlled trials.

Keyphrases

locally advanced
chemotherapy induced
rectal cancer
randomized controlled trial
squamous cell carcinoma
radiation therapy
advanced non small cell lung cancer
papillary thyroid
type diabetes
tyrosine kinase
energy transfer